PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease (Q39003365)

8 September 2017

title

PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease (English)

1 reference

8 September 2017

1 reference

1 reference

Dwayne Brown

1 reference

8 September 2017

Andrea Tamas

series ordinal

1 reference

8 September 2017

Dora Reglodi

series ordinal

1 reference

8 September 2017

Yousef Tizabi

series ordinal

1 reference

8 September 2017

publication date

17 April 2014

1 reference

8 September 2017

published in

Neurotoxicity Research

1 reference

8 September 2017

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

230-239

1 reference

Parkinson's disease and inflammatory changes.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Inflammation and apoptosis: linked therapeutic targets in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Classic and new animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Apoptosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Fc receptors and their interactions with immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Toxic Effects of Low Alcohol and Nicotine Combinations in SH-SY5Y Cells are Apoptotically Mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Neuropeptide pituitary adenylate cyclase‐activating polypeptide (PACAP) slows down Alzheimer's disease‐like pathology in amyloid precursor protein‐transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Inflammation and Parkinsons Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-014-9468-X

Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease

21 January 2018

1 reference

12 December 2020

Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration

1 reference

12 December 2020

Inflammation in Parkinson's disease.

1 reference

12 December 2020

Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors

1 reference

12 December 2020

Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide

1 reference

12 December 2020

Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas

1 reference

12 December 2020

10.1007/S12640-014-9468-X

Identifiers

DOI

1 reference

8 September 2017

1 reference